Income Statement AbClon Inc.

Stocks

A174900

KR7174900001

Pharmaceuticals

End-of-day quote Korea S.E. 2026-09-18			5-day change	1st Jan Change
19,560.00 ^KRW	-2.93%		-6.19%	-53.98%

06-08	Alligator partner Henlius doses first patients in HLX22 study	FW
05-22	Alligator Bioscience comments on Henlius update for HLX22	FW

b8690482ea9259.bZ0r4ozrgYZKy2INyAgWjyGHAyLp4eJmnaxg4IsP368.VapJuv-4sNUJqCpu-GllzHfRTWqZ2IdT_vVYq7J6tJseqUSbyYPVtD2BCQ

Published financial data: ABCLON INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	3.02B	3.41B	2.88B	2.34B	4.71B
Other Revenues, Total	-	-10	-	-	-
Total Revenues	3.02B	3.41B	2.88B	2.34B	4.71B
Cost of Goods Sold, Total	1.42B	1.04B	831M	1.28B	3.6B
Gross Profit	1.6B	2.36B	2.05B	1.06B	1.11B
Selling General & Admin Expenses, Total	1.83B	2.02B	2.45B	2.67B	3.78B
Provision for Bad Debts	-	-	-	-	249M
R&D Expenses	9.63B	8.69B	10.73B	13.39B	14.43B
Depreciation & Amortization - (IS)	130M	170M	196M	197M	179M
Amortization of Goodwill and Intangible Assets - (IS)	38.32M	46.08M	44.9M	56.12M	72.39M
Other Operating Expenses	207M	181M	263M	332M	288M
Other Operating Expenses, Total	11.83B	11.11B	13.69B	16.65B	19B
Operating Income	-10.23B	-8.75B	-11.64B	-15.59B	-17.89B
Interest Expense, Total	-179M	-490M	-1.35B	-900M	-439M
Interest And Investment Income	148M	259M	860M	360M	458M
Net Interest Expenses	-30.44M	-231M	-490M	-540M	18.99M
Currency Exchange Gains (Loss)	-4.33M	26.86M	-32.88M	58.89M	7.57M
Other Non Operating Income (Expenses)	25.94M	-1.39B	-561M	-232M	-47.56M
EBT, Excl. Unusual Items	-10.24B	-10.35B	-12.73B	-16.3B	-17.91B
Gain (Loss) On Sale Of Assets	208K	-628K	-52K	-16K	-3.28M
Asset Writedown	-	-	-164M	-	-
EBT, Incl. Unusual Items	-10.24B	-10.35B	-12.89B	-16.3B	-17.91B
Income Tax Expense	-	-1.1B	10.95M	-	-2.37M
Earnings From Continuing Operations	-10.24B	-9.25B	-12.9B	-16.3B	-17.91B
Net Income to Company	-10.24B	-9.25B	-12.9B	-16.3B	-17.91B
Net Income - (IS)	-10.24B	-9.25B	-12.9B	-16.3B	-17.91B
Preferred Dividend and Other Adjustments	-	-	150M	119M	197M
Net Income to Common Incl Extra Items	-10.24B	-9.25B	-13.05B	-16.42B	-18.1B
Net Income to Common Excl. Extra Items	-10.24B	-9.25B	-13.05B	-16.42B	-18.1B
Per Share Items
Net EPS - Basic	-670.1	-604.48	-849.63	-975.41	-976.02
Basic EPS - Continuing Operations	-670.1	-604.48	-849.63	-975.41	-976.02
Basic Weighted Average Shares Outstanding	15.28M	15.31M	15.36M	16.83M	18.55M
Net EPS - Diluted	-670.1	-604.48	-849.63	-975.41	-976.02
Diluted EPS - Continuing Operations	-670.1	-604.48	-849.63	-975.41	-976.02
Diluted Weighted Average Shares Outstanding	15.28M	15.31M	15.36M	16.83M	18.55M
Normalized Basic EPS	-418.82	-422.49	-517.8	-605.21	-603.35
Normalized Diluted EPS	-418.82	-422.49	-517.8	-605.21	-603.35
Supplemental Items
EBITDA	-8.83B	-7.23B	-9.96B	-14B	-16.76B
EBITA	-10.16B	-8.67B	-11.55B	-15.49B	-17.76B
EBIT	-10.23B	-8.75B	-11.64B	-15.59B	-17.89B
EBITDAR	-8.83B	-7.23B	-9.96B	-14B	-16.76B
Effective Tax Rate - (Ratio)	-	10.58	-0.08	-	0.01
Normalized Net Income	-6.4B	-6.47B	-7.96B	-10.19B	-11.19B
Supplemental Operating Expense Items
Advertising Expense	10M	-	-	-	-
Selling and Marketing Expenses	508M	618M	562M	463M	1.2B
General and Administrative Expenses	10.96M	5.15M	18.45M	14.96M	9.88M
Research And Development Expense From Footnotes	9.63B	8.69B	10.73B	13.39B	14.43B
Net Rental Expense, Total	2.47M	2.56M	3.58M	2.58M	2.88M
Imputed Operating Lease Interest Expense	494K	1.06M	3.17M	1.24M	829K
Imputed Operating Lease Depreciation	1.97M	1.5M	404K	1.33M	2.05M
Maintenance & Repair Expenses, Total	15.57M	14.42M	23.4M	13.6M	28.7M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	408M
Total Stock-Based Compensation	-	-	-	-	408M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	766M	5.3B	12.26B	18.86B	39.01B
Short Term Investments	9.5B	18.84B	5.24B	3B	6B
Total Cash And Short Term Investments	10.27B	24.14B	17.5B	21.86B	45.01B
Accounts Receivable, Total	50.83M	187M	48.06M	171M	280M
Other Receivables	1.01B	353M	34.21M	480M	292M
Total Receivables	1.06B	540M	82.27M	650M	573M
Inventory	7.8M	9.99M	2.19M	7.74M	187M
Prepaid Expenses	63.1M	18.93M	104M	272M	101M
Other Current Assets, Total	488M	287M	1.65B	431M	164M
Total Current Assets	11.89B	25B	19.34B	23.22B	46.04B
Gross Property Plant And Equipment	21.56B	31.7B	31.74B	31.8B	14.96B
Accumulated Depreciation	-4.49B	-4.81B	-6.53B	-7.68B	-6.13B
Net Property Plant And Equipment	17.06B	26.89B	25.2B	24.12B	8.82B
Other Intangibles, Total	428M	429M	534M	506M	490M
Accounts Receivable Long-Term	-500	-330	-30	90	30
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	449M	1.75B	357M	335M	15.4B
Total Assets	29.83B	54.06B	45.44B	48.18B	70.75B
Liabilities
Accounts Payable, Total	112M	138M	235M	20.09M	6.96M
Accrued Expenses, Total	212M	260M	235M	376M	1.61B
Short-term Borrowings	2B	7B	12.53B	17.1B	7B
Current Portion of Long-Term Debt	5B	-	-	-	-
Current Portion of Leases	22.88M	149M	51.1M	142M	39.13M
Other Current Liabilities	2.7B	1.2B	4.57B	468M	696M
Total Current Liabilities	10.04B	8.75B	17.62B	18.11B	9.35B
Long-Term Debt	-	4.56B	-	-	-
Long-Term Leases	70.62M	48.6M	24.66M	9.06M	46.26M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Other Non Current Liabilities	355M	4.09B	565M	661M	909M
Total Liabilities	10.47B	17.46B	18.21B	18.78B	10.31B
Preferred Stock Non Redeemable	-	594M	643M	442M	365M
Total Preferred Equity	-	594M	643M	442M	365M
Common Stock, Total	7.64B	7.66B	7.77B	8.71B	9.86B
Additional Paid In Capital	45.5B	61.24B	64.14B	81.38B	103B
Retained Earnings	-34.56B	-43.81B	-56.58B	-72.88B	-90.79B
Comprehensive Income and Other	778M	10.92B	11.26B	11.75B	37.58B
Total Common Equity	19.36B	36.01B	26.58B	28.96B	60.07B
Total Equity	19.36B	36.6B	27.23B	29.41B	60.44B
Total Liabilities And Equity	29.83B	54.06B	45.44B	48.18B	70.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15.28M	15.32M	15.53M	17.43M	19.73M
ECS Total Common Shares Outstanding	15.28M	15.32M	15.53M	17.43M	19.73M
Book Value / Share	1.27K	2.35K	1.71K	1.66K	3.04K
Tangible Book Value	18.93B	35.58B	26.05B	28.46B	59.58B
Tangible Book Value Per Share	1.24K	2.32K	1.68K	1.63K	3.02K
Total Debt	7.09B	11.76B	12.6B	17.25B	7.09B
Net Debt	-3.17B	-12.38B	-4.9B	-4.61B	-37.93B
Debt Equivalent Oper. Leases	19.74M	20.46M	28.62M	20.6M	23.01M
Inventories - Finished Goods, Total	7.8M	9.99M	2.19M	7.74M	187M
Inventories - Others	-	-350	-50	250	-120
Land - (BS)	11.45B	19.08B	19.08B	19.08B	4.07B
Buildings, Total	4.24B	6.76B	6.76B	6.76B	5.75B
Machinery, Total	5.41B	5.33B	5.5B	5.56B	4.77B
Accumulated Allowance for Doubtful Accounts (Supple)	513K	1.89M	485K	57.95M	79.1M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	-10.24B	-9.25B	-12.9B	-16.3B	-17.91B
Depreciation & Amortization - CF	1.33B	1.44B	1.59B	1.49B	1B
Amortization of Goodwill and Intangible Assets - (CF)	68.32M	76.08M	90.96M	102M	122M
Depreciation & Amortization, Total	1.39B	1.52B	1.68B	1.59B	1.13B
(Gain) Loss From Sale Of Asset	-208K	628K	52K	16K	3.28M
Asset Writedown & Restructuring Costs	-	-	164M	-	-
Stock-Based Compensation (CF)	501M	288M	328M	496M	809M
Provision and Write-off of Bad Debts	-820K	1.38M	-1.4M	57.46M	21.15M
Other Operating Activities, Total	278M	474M	1.61B	772M	98.68M
Change In Accounts Receivable	81.86M	-138M	152M	-180M	-131M
Change In Inventories	8.88M	-2.18M	7.8M	-5.55M	-179M
Change In Accounts Payable	-102M	25.71M	97.17M	-215M	-13.1M
Change in Other Net Operating Assets	-566M	-405M	-617M	-609M	2.34B
Cash from Operations	-8.64B	-7.49B	-9.48B	-14.39B	-13.83B
Capital Expenditure	-505M	-75.63M	-45.94M	-167M	-594M
Sale of Property, Plant, and Equipment	231K	-	-	-	-
Sale (Purchase) of Intangible assets	-17.48M	-14.08M	-3.9M	-630K	-23.94M
Investment in Marketable and Equity Securities, Total	8.51B	-9.34B	13.6B	2.24B	-3B
Other Investing Activities, Total	0	-30.5M	-10	-	-156M
Cash from Investing	7.99B	-9.46B	13.55B	2.07B	-3.77B
Long-Term Debt Issued, Total	-	10B	-	10.1B	25.16B
Total Debt Issued	-	10B	-	10.1B	25.16B
Long-Term Debt Repaid, Total	-117M	-144M	-164M	-165M	-10.28B
Total Debt Repaid	-117M	-144M	-164M	-165M	-10.28B
Issuance of Common Stock	-	70M	85M	17M	12.17B
Issuance of Preferred Stock	-	12B	3B	8.9B	10.78B
Other Financing Activities, Total	-	-440M	-29.2M	-8.58M	-95.87M
Cash from Financing	-117M	21.49B	2.89B	18.84B	37.74B
Foreign Exchange Rate Adjustments	-1.27M	48.6K	430K	83.45M	14.81M
Net Change in Cash	-774M	4.53B	6.96B	6.61B	20.15B
Supplemental Items
Cash Interest Paid	164M	251M	375M	372M	452M
Cash Income Tax Paid (Refund)	-31.89M	-4.06M	125M	-95.67M	-8.96M
Levered Free Cash Flow	-4.77B	-5B	-3.9B	-12.58B	-8.75B
Unlevered Free Cash Flow	-4.66B	-4.69B	-3.06B	-12.02B	-8.48B
Change In Net Working Capital	-862M	650M	-2.59B	3.7B	-1.79B
Net Debt Issued / Repaid	-117M	9.86B	-164M	9.93B	14.88B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	-18.28	-13.04	-14.64	-20.81	-18.8
Return on Total Capital	-20.3	-14.62	-16.48	-22.53	-19.58
Return On Equity %	-42.05	-33.07	-40.35	-57.57	-39.86
Return on Common Equity	-42.05	-33.43	-41.62	-59.12	-40.67
Margin Analysis
Gross Profit Margin %	53.11	69.4	71.13	45.44	23.58
SG&A Margin	60.66	59.4	85.29	114.23	80.1
EBITDA Margin %	-292.72	-212.32	-346.21	-598.27	-355.49
EBITA Margin %	-336.67	-254.63	-401.59	-661.91	-376.81
EBIT Margin %	-338.93	-256.86	-404.75	-666.24	-379.4
Income From Continuing Operations Margin %	-339.22	-271.66	-448.53	-696.7	-379.86
Net Income Margin %	-339.22	-271.66	-448.53	-696.7	-379.86
Net Avail. For Common Margin %	-339.22	-271.66	-453.74	-701.79	-384.04
Normalized Net Income Margin	-212.02	-189.87	-276.53	-435.44	-237.4
Levered Free Cash Flow Margin	-158.1	-146.71	-135.58	-537.64	-185.61
Unlevered Free Cash Flow Margin	-154.4	-137.72	-106.25	-513.6	-179.8
Asset Turnover
Asset Turnover	0.09	0.08	0.06	0.05	0.08
Fixed Assets Turnover	0.17	0.16	0.11	0.09	0.29
Receivables Turnover (Average Receivables)	33.01	28.63	23.34	21.39	20.91
Inventory Turnover (Average Inventory)	115.56	117.17	136.48	257.23	37.08
Short Term Liquidity
Current Ratio	1.18	2.86	1.1	1.28	4.92
Quick Ratio	1.13	2.82	1	1.24	4.87
Operating Cash Flow to Current Liabilities	-0.86	-0.86	-0.54	-0.79	-1.48
Days Sales Outstanding (Average Receivables)	11.06	12.75	15.64	17.11	17.46
Days Outstanding Inventory (Average Inventory)	3.16	3.11	2.67	1.42	9.84
Average Days Payable Outstanding	42.3	43.7	82.64	36.37	1.31
Cash Conversion Cycle (Average Days)	-28.09	-27.84	-64.32	-17.84	26
Long Term Solvency
Total Debt/Equity	36.64	32.13	46.28	58.66	11.72
Total Debt / Total Capital	26.82	24.31	31.64	36.97	10.49
LT Debt/Equity	0.36	12.59	0.09	0.03	0.08
Long-Term Debt / Total Capital	0.27	9.53	0.06	0.02	0.07
Total Liabilities / Total Assets	35.1	32.29	40.08	38.97	14.57
EBIT / Interest Expense	-57.23	-17.87	-8.62	-17.32	-40.77
EBITDA / Interest Expense	-49.43	-14.77	-7.38	-15.55	-38.2
(EBITDA - Capex) / Interest Expense	-52.25	-14.93	-7.41	-15.74	-39.55
Total Debt / EBITDA	-0.8	-1.63	-1.27	-1.23	-0.42
Net Debt / EBITDA	0.36	1.71	0.49	0.33	2.26
Total Debt / (EBITDA - Capex)	-0.76	-1.61	-1.26	-1.22	-0.41
Net Debt / (EBITDA - Capex)	0.34	1.69	0.49	0.33	2.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.91	12.87	-15.49	-18.67	101.47
Gross Profit, 1 Yr. Growth %	33.91	47.5	-13.81	-48.04	4.53
EBITDA, 1 Yr. Growth %	62.32	-18.13	37.91	40.54	19.72
EBITA, 1 Yr. Growth %	56.07	-14.64	33.36	34.04	14.69
EBIT, 1 Yr. Growth %	55.66	-14.46	33.24	33.87	14.73
Earnings From Cont. Operations, 1 Yr. Growth %	58.85	-9.61	39.6	26.33	9.85
Net Income, 1 Yr. Growth %	58.85	-9.61	39.6	26.33	9.85
Normalized Net Income, 1 Yr. Growth %	58.85	1.08	23.13	28.06	9.84
Diluted EPS Before Extra, 1 Yr. Growth %	49.82	-9.78	38.83	14.75	0.1
Accounts Receivable, 1 Yr. Growth %	-61.5	268.11	-75.79	255.24	64.15
Inventory, 1 Yr. Growth %	-53.24	27.98	-78.11	254.05	2.31K
Net Property, Plant and Equip., 1 Yr. Growth %	-4.63	57.57	-6.26	-4.31	-63.42
Total Assets, 1 Yr. Growth %	-25.67	81.24	-15.89	6.05	46.83
Tangible Book Value, 1 Yr. Growth %	-34.47	87.95	-27.06	9.25	109.38
Common Equity, 1 Yr. Growth %	-33.99	86.01	-26.45	8.95	107.41
Cash From Operations, 1 Yr. Growth %	53.02	-13.32	26.59	51.78	-3.93
Capital Expenditures, 1 Yr. Growth %	-85.31	-85.04	-39.25	263.19	255.81
Levered Free Cash Flow, 1 Yr. Growth %	-33.33	4.74	-23.88	222.5	-29.36
Unlevered Free Cash Flow, 1 Yr. Growth %	-33.8	0.68	-36.57	293.14	-28.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-54.18	10.87	-2.36	-17.09	28
Gross Profit, 2 Yr. CAGR %	-64.86	40.54	12.99	-33.08	-26.3
EBITDA, 2 Yr. CAGR %	35.89	15.28	6.18	39.22	29.71
EBITA, 2 Yr. CAGR %	53.13	15.42	6.64	33.7	23.99
EBIT, 2 Yr. CAGR %	54.53	15.39	6.7	33.55	23.93
Earnings From Cont. Operations, 2 Yr. CAGR %	99.72	19.83	12.27	32.8	17.8
Net Income, 2 Yr. CAGR %	99.72	19.83	12.27	32.8	17.8
Normalized Net Income, 2 Yr. CAGR %	47.51	26.72	11.5	25.57	18.6
Diluted EPS Before Extra, 2 Yr. CAGR %	94.57	16.25	12.61	26.25	7.16
Accounts Receivable, 2 Yr. CAGR %	-47.6	19.05	-2.76	-7.26	141.48
Inventory, 2 Yr. CAGR %	-51.11	-22.64	-47.08	-11.97	823.91
Net Property, Plant and Equip., 2 Yr. CAGR %	5.86	22.59	21.54	-5.29	-40.84
Total Assets, 2 Yr. CAGR %	-20.31	16.07	23.42	-5.56	24.78
Tangible Book Value, 2 Yr. CAGR %	-26.22	10.98	17.3	-10.73	51.24
Common Equity, 2 Yr. CAGR %	-25.82	10.8	17.18	-10.48	50.33
Cash From Operations, 2 Yr. CAGR %	338.31	15.17	4.75	38.61	20.75
Capital Expenditures, 2 Yr. CAGR %	-78.12	-85.17	-69.85	48.54	259.48
Levered Free Cash Flow, 2 Yr. CAGR %	-36.57	-16.44	-9.58	56.68	49.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	-37.11	-18.36	-19.01	57.92	66.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-8.35	-38.12	1.26	-8.13	11.46
Gross Profit, 3 Yr. CAGR %	-10.72	-43.32	19.57	-12.79	-22.35
EBITDA, 3 Yr. CAGR %	76.66	14.77	22.32	16.58	32.39
EBITA, 3 Yr. CAGR %	74.18	26.03	21.07	15.08	27.04
EBIT, 3 Yr. CAGR %	73.58	26.88	21.01	15.08	26.96
Earnings From Cont. Operations, 3 Yr. CAGR %	129.89	53.34	26.04	16.77	24.66
Net Income, 3 Yr. CAGR %	129.89	53.34	26.04	16.77	24.66
Normalized Net Income, 3 Yr. CAGR %	78.63	30.05	25.47	16.77	20.09
Diluted EPS Before Extra, 3 Yr. CAGR %	75.96	50.59	23.85	13.34	16.83
Accounts Receivable, 3 Yr. CAGR %	-40.48	0.36	-28.6	49.76	12.18
Inventory, 3 Yr. CAGR %	-24.26	-32.62	-49.21	-0.28	165.35
Net Property, Plant and Equip., 3 Yr. CAGR %	49.71	20.87	12.1	12.23	-31.03
Total Assets, 3 Yr. CAGR %	1.29	4.8	4.23	17.33	9.41
Tangible Book Value, 3 Yr. CAGR %	1.09	0.76	-3.39	14.55	18.6
Common Equity, 3 Yr. CAGR %	1.16	0.78	-3.22	14.37	18.46
Cash From Operations, 3 Yr. CAGR %	32.51	155.37	18.86	18.53	22.67
Capital Expenditures, 3 Yr. CAGR %	-40.18	-80.72	-76.28	-30.89	98.75
Levered Free Cash Flow, 3 Yr. CAGR %	37.37	-25.03	-18.32	38.15	19.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	35.35	-26.43	-24.27	37.13	20.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.66	-0.72	-6	-30.45	11.21
Gross Profit, 5 Yr. CAGR %	-1.89	3.44	-1.9	-39.37	-1.47
EBITDA, 5 Yr. CAGR %	46.71	42.07	44.11	23.95	25.22
EBITA, 5 Yr. CAGR %	45.17	41.79	43.14	29.01	22.23
EBIT, 5 Yr. CAGR %	44.82	41.45	42.88	29.48	22.17
Earnings From Cont. Operations, 5 Yr. CAGR %	45.01	44.23	72.59	44.74	22.68
Net Income, 5 Yr. CAGR %	45.01	44.23	72.59	44.74	22.68
Normalized Net Income, 5 Yr. CAGR %	46.07	48.66	47.94	28.21	22.68
Diluted EPS Before Extra, 5 Yr. CAGR %	20.66	20.8	47.19	40.68	16.89
Accounts Receivable, 5 Yr. CAGR %	-28.98	-1.09	-27.57	-1.6	16.25
Inventory, 5 Yr. CAGR %	26.28	-11.32	-34.38	-25.02	62.07
Net Property, Plant and Equip., 5 Yr. CAGR %	39.41	54.7	37.73	9.64	-13.19
Total Assets, 5 Yr. CAGR %	13.25	20.97	9.62	0.51	12.01
Tangible Book Value, 5 Yr. CAGR %	9.96	15.72	7.29	-3.93	15.58
Common Equity, 5 Yr. CAGR %	10.08	15.67	7.29	-3.81	15.42
Cash From Operations, 5 Yr. CAGR %	111.36	46.38	20.62	100	19.61
Capital Expenditures, 5 Yr. CAGR %	64.32	3.5	-54.52	-56.37	-29.63
Levered Free Cash Flow, 5 Yr. CAGR %	75.77	39.74	16.21	1.19	4.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	78.95	38.87	10.22	0.39	3.79